Clinical Trial Update: Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 Clinical Study of UTD1 Injection combined with Capecitabine in advanced/metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• UTD1 Injection

Snippet

Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd. | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED